Literature DB >> 3280001

Immunofluorescent studies in ocular cicatricial pemphigoid.

J N Leonard1, C M Hobday, G P Haffenden, C E Griffiths, A V Powles, P Wright, L Fry.   

Abstract

Twenty nine patients with cicatrizing conjunctivitis were studied; 17 with a clinical diagnosis of cicatricial pemphigoid, five with a clinical diagnosis of pseudopemphigoid caused by long-term application of topical medication and seven who had a cicatrizing conjunctivitis from other causes. Biopsies from clinically uninvolved bulbar conjunctiva were taken for direct immunofluorescence and blood was taken for indirect immunofluorescence using normal human conjunctiva, oral mucosa and skin as substrates. On direct immunofluorescence, in vivo bound immunoglobulins were found along the basement membrane in 10 of the 17 patients with cicatricial pemphigoid, one of the five with pseudopemphigoid and two of the seven with a cicatrizing conjunctivitis associated with other diseases. Circulating anti-basement membrane zone antibodies were found only when conjunctiva was used as a substrate. These were present in seven of the patients with cicatricial pemphigoid, three of those with pseudopemphigoid and two of those with a cicatrizing conjunctivitis caused by other diseases. These results indicate that direct immunofluorescence is a useful, but not absolute diagnostic marker for ocular cicatricial pemphigoid. The results in the pseudopemphigoid group argue that this is an immunologically mediated disorder indistinguishable from spontaneous cicatricial pemphigoid and probably triggered by the drugs. The presence of circulating antibodies should allow for precise identification of the antigen involved in cicatricial pemphigoid using SDS electrophoresis and Western blot analysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280001     DOI: 10.1111/j.1365-2133.1988.tb01776.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 2.  Adverse effects of topical antiglaucomatous medications on the conjunctiva.

Authors:  D Broadway; I Grierson; R Hitchings
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

3.  The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation.

Authors:  W Bernauer; M J Elder; J N Leonard; P Wright; J K Dart
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

4.  Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand.

Authors:  Samantha Bobba; Connor Devlin; Nick Di Girolamo; Denis Wakefield; Peter McCluskey; Elsie Chan; Mark Daniell; Stephanie Watson
Journal:  Eye (Lond)       Date:  2018-06-19       Impact factor: 3.775

Review 5.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

6.  Progression of disease in ocular cicatricial pemphigoid.

Authors:  M J Elder; W Bernauer; J Leonard; J K Dart
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

7.  A gut connection in mucous membrane pemphigoid: Insights into the role of the microbiome.

Authors:  Abdelrahman M Elhusseiny; Hoda Fakhari; Faraz Bishehsari; Kai Kang; Ali R Djalilian
Journal:  Ocul Surf       Date:  2019-09-18       Impact factor: 5.033

8.  Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis.

Authors:  W Bernauer; P Wright; J K Dart; J N Leonard; S Lightman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-10       Impact factor: 3.117

Review 9.  A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.

Authors:  Brendon W H Lee; Jeremy C K Tan; Melissa Radjenovic; Minas T Coroneo; Dedee F Murrell
Journal:  Orphanet J Rare Dis       Date:  2018-05-22       Impact factor: 4.123

10.  Treatment strategies in mucous membrane pemphigoid.

Authors:  Ann G Neff; Matthew Turner; Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.